Advantages of the Molecular Structure of Aflibercept

Opinion
Video

Panelists discuss how aflibercept’s molecular structure contributes to its clinical efficacy as a standard treatment for retinal vascular diseases.

Video content above is prompted by the following:

  • Aflibercept 2 mg is considered the standard of care for retinal vascular diseases. Can you briefly explain the structure of the aflibercept molecule and its significance?
Recent Videos
3 experts are featured in this series.
3 experts are featured in this series.
2 experts in this video
2 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
AAO 2024: Bonnie An Henderson, MD, talks about advancing medical education with AI, robotics, and diverse learning methods
Related Content
An elderly man undergoes an eye exam in a clinic. Image credit: ©Vladislav – stock.adobe.com

NeurEYE research team leads AI-supported dementia detection programme with Scottish optometrists

Hattie Hayes
January 22nd 2025
Article

Predictive software will use retinal imaging to identify patient risk for Alzheimer and other neurodegenerative diseases

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

Systane Ultra PF voluntary recall: Protecting patients from potential risk of fungal material in one lot

Systane Ultra PF voluntary recall: Protecting patients from potential risk of fungal material in one lot

Lynda Charters;Sheryl Stevenson
December 27th 2024
Article

Alcon Laboratories is voluntarily recalling one lot (Lot 10101) of its Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count, after identifying fungal contamination in a sealed vial.

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A picture of a scale on a laptop computer. One side of the scale holds a human brain, the other holds a laptop, symbolising artificial intelligence. Image credit: ©Who is Danny – stock.adobe.com

Balancing the promises and challenges of artificial intelligence

Polat Goktas, PhD;Andrzej Grzybowski, MD, PhD, MBA, MAE
December 18th 2024
Article

Sophisticated programmes require an evolving mindset

A doctor looks at a patient's chest x-ray. Image credit: ©Chinnapong – stock.adobe.com

Ocular tuberculosis and relapse rates for recurrence of uveitis

Lynda Charters
November 26th 2024
Article

Uveitic relapses primarily manifest as anterior uveitis, the authors said

© 2025 MJH Life Sciences

All rights reserved.